Clinical Trial Update: Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

View source ↗

Summary

A clinical trial update describing pro-coagulant markers and anticoagulant failure in cancer patients at risk for recurrence of venous thromboembolism; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Venous Thromboembolism, Deep-Vein Thrombosis | Status: COMPLETED